Category: Parkinson’s News

The man who steered the Hollywood-owned Wrexham to three promotions in a row warns there will be no loss of focus after a significant jump up the table.

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced that ISM8969, an orally available NLRP3 inhibitor targeting inflammation and neurodegenerative disorders, has recently received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA), intended for the treatment of Parkinson’s Disease.

Scientists report that specific RNA patterns in blood may detect Parkinson’s disease early, opening a window for earlier care and trials.

Launched in 2019, the free event series has traveled to 18 locations nationwide, empowering people with Parkinson’s to better manage the disease, learn about…

A challenging cycling fundraiser inspired by family connection and a shared love of the sport has successfully raised $6,732 for Parkinson’s NSW, delivering meaningful support to people living with the disease and their families.

A Danish study of 17,711 patients finds depression emerging later in life is more common before Parkinson’s and Lewy body dementia diagnoses, suggesting it may…

A recent phase 2b study reveals mesdopetam’s potential in reducing dyskinesia severity in Parkinson disease, despite no significant ON time improvement.

Depression that appears later in life is often viewed as a response to declining health, but emerging evidence suggests it may sometimes signal deeper neurological changes.

A new imaging-drug collaboration aims to show whether progression of Parkinson’s disease can be slowed, not just managed.